HOME >> BIOLOGY >> NEWS
Obesity Gene: Possible Link To Heart Disease Risk

DALLAS, June 12 -- A link has been found between leptin, a protein product of the obesity gene, and risk for coronary heart disease, the cause of heart attacks, say researchers in a study published today in an American Heart Association journal.

The obesity gene was cloned in 1994. Its product, leptin, acts as a signal to help the body decide when it has eaten enough food to feel full. The amount of leptin in the blood has been directly linked to body fat.

This study is the first to associate leptin elevations in the blood with so-called insulin resistance syndrome. The syndrome -- characterized by high blood pressure, low levels of the "good" high-density lipoprotein cholesterol and elevations in insulin -- sets the stage for heart disease. Insulin is a hormone that helps the body use glucose, its main fuel. An excess of insulin (a condition called insulin resistance) indicates the body is not processing glucose normally.

The study was conducted by researchers in the Wynn department of metabolic medicine of the Imperial College School of Medicine, London.

In the study, which appears in Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association, researchers measured blood leptin levels in 74 men. They found that the higher the level of leptin the more likely the men were to have the syndrome, and thus "perhaps a greater heart disease risk," says Francisco Leyva, M.D., specialist registrar in cardiology at Charing Cross Hospital.

"We have found that leptin concentrations are related to the metabolic disturbances that constitute the syndrome, especially insulin resistance," says Leyva. "Futher studies are needed to determine whether insulin and leptin play a coordinating role in this syndrome and whether leptin concentrations could provide an additional measure of heart risk.

"Measuring leptin might become a new way to determine a person's risk of heart dis
'"/>

Contact: Carole Bullock
caroleb@amhrt.org
214-706-1279
American Heart Association
11-Jun-1998


Page: 1 2

Related biology news :

1. Obesity and hypertension: Two epidemics or one?
2. Obesity alone not a good predictor of cardiovascular risk and death, fat distribution proved best
3. Obesity drug inhibits prostate tumor growth
4. Obesity and blood pressure
5. Obesity, kidney genetics, erectile dysfunction among highlighted research at APS Meeting
6. Obesity in Costa Rican children alarming, likely future health burden
7. Obesity prevention program aimed at second graders
8. Obesity not a personal failing, but a battle against biology
9. Obesity sleuths find chronic diseases linked to behavior contrary our DNA
10. Obesity...by choice
11. Obesity may exacerbate a heart disorder in African American females

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/22/2016)... 2016  The American College of Medical Genetics and Genomics ... as one of the fastest-growing trade shows during the ... Bellagio in Las Vegas . ... growth in each of the following categories: net square feet ... of attendees. The 2015 ACMG Annual Meeting was ranked 23 ...
(Date:6/22/2016)... -- On Monday, the Department of Homeland Security (DHS) ... for the Biometric Exit Program. The Request for Information ... explains that CBP intends to add biometrics to confirm ... States , in order to deter visa overstays, ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/20/2016)... , June 20, 2016 Securus ... justice technology solutions for public safety, investigation, corrections ... the prisons involved, it has secured the final ... (DOC) facilities for Managed Access Systems (MAS) installed. ... additional facilities to be installed by October, 2016. ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
Cached News: